Sort
39,280 grants matching “leukemia”
Pharmacological modulation of epigenetic changes in AML
$322,878Guido Marcucci · Ohio State University · R01 · FY2013 · CA
Pretargeted Radioimmunotherapy for Hematologic Malignancies
$322,824Oliver W. Press · Fred Hutchinson Cancer Research Center · P01 · FY2012 · CA
SLEEP, FATIGUE, AND DEXAMETHOSONE IN CHILDHOOD CANCER
$322,811St. Jude Children'S Research Hospital · R01 · FY2003 · NR
Mechanisms promoting translocations and mature B cell lymphomas
$322,806Jing Hong Wang · University Of Colorado Denver · R01 · FY2015 · CA
Targeting Cancer Stem Cells
$322,801Richard J Jones · Johns Hopkins University · P01 · FY2013 · CA
GENETIC ANALYSIS OF MYELOPROLIFERATIVE DISEASE
$322,746Roswell Park Cancer Institute Corp · R01 · FY2002 · CA
GENE THERAPY BY PHENOTYPIC KNOCKOUT OF HIV CORECEPTORS
$322,698Dana-Farber Cancer Institute · R01 · FY2001 · AI
Notch signaling in B cell development and survival
$322,673University Of Pennsylvania · R01 · FY2002 · CA
Coordination of the actin and microtubule cytoskeletons
$322,667Bruce L Goode · Brandeis University · R01 · FY2014 · GM
Coordination of the actin and microtubule cytoskeletons
$322,667Bruce L Goode · Brandeis University · R01 · FY2015 · GM
Development of novel anti-leukemia agents targeting the menin-MLL interaction
$322,664Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Development of novel anti-leukemia agents targeting the menin-MLL interaction
$322,664Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2011 · CA
CHARACTERIZATION OF RECURRENT ADJACENT GENE TRANSLOCATIONS IN BREAST CANCER
$322,663Xiaosong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · CA
Delta-like ligand 4+ dendritic cells and induction of alloimmunity
$322,663Yi Zhang · University Of Michigan At Ann Arbor · R01 · FY2013 · CA
Role of noncoding RNA in Regulating GVHD
$322,663Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Development of a dual small-molecule BCl-XL/BCL-2 inhibitor for non-small cell lu
$322,663Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
Development of novel anti-leukemia agents targeting the menin-MLL interaction
$322,663Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
Role of noncoding RNA in Regulating GVHD
$322,663Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Role of noncoding RNA in Regulating GVHD
$322,663Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2013 · CA
Oncogene Cooperativity in Leukemia Stem Cells
$322,663Craig T. Jordan · University Of Colorado Denver · R01 · FY2016 · CA
Role of noncoding RNA in Regulating GVHD
$322,663Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
Cytokines in Glial Cells and EAE Brain
$322,656Inderjit Singh · Medical University Of South Carolina · R01 · FY2010 · NS
Gleevec plus novel anti-Bcr-Abl strategies in Leukemias
$322,625H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2002 · CA
Gleevec plus novel anti-Bcr-Abl strategies in Leukemias
$322,625H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2004 · CA
Gleevec plus novel anti-Bcr-Abl strategies in Leukemias
$322,625H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2003 · CA